Adello Biologics Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 125

Employees

  • Latest Deal Type
  • M&A

Adello Biologics General Information

Description

Operator of a biotechnology company intended to provide affordable biosimilars to patients worldwide. The company utilizes approved biosimilars to make drugs that are similar in quality, safety and effectiveness to an existing branded biologic, enabling patients and providers to reduce costs and improve access to important treatments.

Contact Information

Formerly Known As
Therapeutic Proteins
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 20 New England Avenue
  • Piscataway, NJ 08854
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 20 New England Avenue
  • Piscataway, NJ 08854
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adello Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 03-Jan-2019 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Later Stage VC 28-Jul-2010 $8.4M $9.4M Completed Generating Revenue
1. Early Stage VC 01-Jul-2005 $1M $1M Completed Product Development
To view Adello Biologics’s complete valuation and funding history, request access »

Adello Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to provide affordable biosimilars to patients worldwide. The company utiliz
Drug Discovery
Piscataway, NJ
125 As of 2016

Martinsried, Germany
 

Madrid, Spain
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adello Biologics Competitors (14)

One of Adello Biologics’s 14 competitors is Formycon, a Formerly VC-backed company based in Martinsried, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Formycon Formerly VC-backed Martinsried, Germany
mAbxience Corporate Backed or Acquired Madrid, Spain
Nevian Lifescience Corporate Backed or Acquired Dhaka, Bangladesh
Genentech Formerly VC-backed South San Francisco, CA
Bristol-Myers Squibb Corporation Princeton, NJ
You’re viewing 5 of 14 competitors. Get the full list »

Adello Biologics Patents

Adello Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160091424-A1 Blood analyzer and blood analyzing method Active 26-Sep-2014
US-9500581-B2 Blood analyzer and blood analyzing method Active 26-Sep-2014
EP-3096744-A1 Thermodynamic equivalence surrogate test (test) for bioequivalence Inactive 22-Jan-2014
EP-3096744-A4 Thermodynamic equivalence surrogate test (test) for bioequivalence Inactive 22-Jan-2014
US-20140024105-A1 Baffled single use bioreactor Active 21-Jul-2012 C12M27/20
To view Adello Biologics’s complete patent history, request access »

Adello Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adello Biologics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capital Midwest Fund Venture Capital Minority
Tarsadia Investments Family Office Minority
University Technology Park Accelerator/Incubator
To view Adello Biologics’s complete investors history, request access »

Adello Biologics FAQs

  • When was Adello Biologics founded?

    Adello Biologics was founded in 2003.

  • Where is Adello Biologics headquartered?

    Adello Biologics is headquartered in Piscataway, NJ.

  • What is the size of Adello Biologics?

    Adello Biologics has 125 total employees.

  • What industry is Adello Biologics in?

    Adello Biologics’s primary industry is Drug Discovery.

  • Is Adello Biologics a private or public company?

    Adello Biologics is a Private company.

  • What is Adello Biologics’s current revenue?

    The current revenue for Adello Biologics is .

  • How much funding has Adello Biologics raised over time?

    Adello Biologics has raised $9.4M.

  • Who are Adello Biologics’s investors?

    Capital Midwest Fund, Tarsadia Investments, and University Technology Park have invested in Adello Biologics.

  • Who are Adello Biologics’s competitors?

    Formycon, mAbxience, Nevian Lifescience, Genentech, and Bristol-Myers Squibb are some of the 14 competitors of Adello Biologics.

  • When was Adello Biologics acquired?

    Adello Biologics was acquired on 03-Jan-2019.

  • Who acquired Adello Biologics?

    Adello Biologics was acquired by Kashiv BioSciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process